Showing results (171-180 of 199) with videos related to

Sort By:
Pageof 20
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1985
Adjuvant CMFP versus CMFP plus tamoxifen versus observation alone in postmenopausal, node-positive breast cancer patients: three-year results of an Eastern Cooperative Oncology Group studyS G Taylor, L A Kalish, J E Olson, et al.
Investigational New Drugs|January 1, 1987
Phase II evaluation of dibromodulcitol and actinomycin D, hydroxyurea, and cyclophosphamide in previously untreated patients with malignant melanomaD A Amato, H Bruckner, D Guerry, et al.
Cancer|April 1, 1975
A clinical trial of the oral form of 4'-demethyl-epipodophyllotoxin-beta-D ethylidene glucoside (NSC 141540) VP 16-213G Falkson, J J van Dyk, E B van Eden, et al.
Cancer|November 1, 1987
A random phase II study of mitoxantrone and cisplatin in patients with hepatocellular carcinoma. An ECOG studyG Falkson, L M Ryan, L A Johnson, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1980
A phase II study of neocarzinostatin (NSC 157365) in malignant hepatoma. An Eastern Cooperative Oncology Group pilot studyG Falkson, D Von Hoff, D Klaassen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1992
Prognosis and other clinical correlates of pathologic review in stage I and II testicular carcinoma: a report from the Testicular Cancer Intergroup StudyI A Sesterhenn, R B Weiss, F K Mostofi, et al.
Cancer|March 15, 1997
The role of radiotherapy in the management of operable locally advanced breast carcinoma: results of a randomized trial by the Eastern Cooperative Oncology GroupJ E Olson, D Neuberg, K J Pandya, et al.
Cancer|January 1, 1981
The superiority of CCNU in the treatment of advanced Hodgkin's disease: Cancer and Leukemia Group B StudyH H Hansen, O S Selawry, T F Pajak, et al.
Cancer Investigation|January 1, 1992
Hexamethylmelamine and low or moderate dose cisplatin with or without pyridoxine for treatment of advanced ovarian carcinoma: a study of the Eastern Cooperative Oncology GroupP H Wiernik, B Yeap, S E Vogl, et al.
Cancer|January 1, 1986
A phase I/II investigation of trioxifene mesylate in advanced breast cancer. Clinical and endocrinologic effectsR S Witte, B Pruitt, D C Tormey, et al.
Pageof 20